JP Morgan Maintains Neutral on Quest Diagnostics, Raises Price Target to $155

Quest Diagnostics Incorporated -0.57%

Quest Diagnostics Incorporated

DGX

146.01

-0.57%

JP Morgan analyst Lisa Gill maintains Quest Diagnostics (NYSE: DGX) with a Neutral and raises the price target from $152 to $155.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via